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To interrogate endogenous p21WAF1/CIP1 (p21) promoter activity under basal conditions and in response to
various forms of stress, knock-in imaging reporter mice in which expression of firefly luciferase (FLuc) was
placed under the control of the endogenous p21 promoter within the Cdkn1a gene locus were generated.
Bioluminescence imaging (BLI) of p21 promoter activity was performed noninvasively and repetitively in mice
and in cells derived from these mice. We demonstrated that expression of FLuc accurately reported endogenous
p21 expression at baseline and under conditions of genotoxic stress and that photon flux correlated with mRNA
abundance and, therefore, bioluminescence provided a direct readout of p21 promoter activity in vivo. BLI
confirmed that p53 was required for activation of the p21 promoter in vivo in response to ionizing radiation.
Interestingly, imaging of reporter cells demonstrated that p53 prevents the extracellular signal-regulated
kinase/mitogen-activated protein kinase pathway from activating p21 expression when quiescent cells are
stimulated with serum to reenter the cell cycle. In addition, low-light BLI identified p21 expression in specific
regions of individual organs that had not been observed previously. This inducible p21FLuc knock-in reporter
strain will facilitate imaging studies of p53-dependent and -independent stress responses within the physio-
logical context of the whole animal.
p21Waf1/CIP1 (p21 here) encodes a member of the CIP/KIP
family of cyclin-dependent protein kinase (CDK) inhibitors
that regulates a variety of complex and sometimes opposing
cell processes. One of the best-characterized properties of p21
is its ability to impair cell cycle advancement by binding to and
inhibiting CDKs (1). Indeed, p21 is a transcriptional target of
p53 and, in cells experiencing genotoxic stress, is critical for
arresting cells in the G1 phase of the cell division cycle through
its binding to CDK2 complexes (35). Furthermore, p21 helps
to sustain a G2 arrest by binding to CDK1 complexes. It has
been reported that the extracellular signal-regulated kinase
(ERK)/mitogen-activated protein kinase (MAPK) pathway ac-
tivates p21 expression in response to serum stimulation (6, 25),
but the impact of p53 was not fully characterized. Paradoxi-
cally, p21 also positively regulates cell cycle progression by
aiding in the assembly of stable CDK4/6-cyclin D complexes
(34).
In addition to regulating cell cycle progression, p21 binds to
proliferating cell nuclear antigen (PCNA), a DNA polymerase
 processivity factor, thereby blocking processive DNA synthe-
sis (26). Interactions between p21 and PCNA have also been
reported to hinder DNA repair (8). p21 can also repress tran-
scription indirectly by inhibiting cyclin-CDK complexes, which
in turn prevent phosphorylation of Rb family proteins (34).
In addition, p21 can modulate transcription directly by bind-
ing to various transcription factors, such as E2F1, STAT3,
and MYC (1).
The cytoplasmic pool of p21 has been shown to regulate
apoptosis as well as the actin cytoskeleton. p21 inhibits apop-
tosis by binding to and inhibiting the activity of proteins that
induce apoptosis, including procaspase 3, caspases 8 and 10,
and the protein kinases SAPK and ASK1. p21 also regulates
the actin cytoskeleton by inhibiting ROCK (5, 23). Inhibition
of ROCK may also be selected for during tumor progression
to enhance cell motility. Indeed, high levels of cytoplasmic
p21 have been observed in a number of human cancers and
are associated with high-grade tumor types and a poor prog-
nosis (3).
Given the multifaceted and complex functions of p21 in vivo,
it is not surprising that the p21 promoter is controlled by a
plethora of signaling pathways (epidermal growth factor
[EGF], nerve growth factor, transforming growth factor ,
gamma interferon, interleukin-6, progesterone, and the Ras/
Raf pathways) and transcription factors (p53, SP1/3, AP2,
STAT1/3/5, E2F1/3, SMAD3/4, and c/EBP/) (1, 14). North-
ern blot analysis and in situ hybridization have been used to
examine p21 expression in various mouse organs ex vivo at
baseline and following exposure of mice to various forms of
genotoxic stress (7, 27, 30). However, there are significant
discrepancies among these studies regarding which tissues
have high versus low versus undetectable levels of p21 mRNA
as well as the contribution made by p53 to basal expression of
p21. In particular, the small intestine has been reported to
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show undetectable (38), low (29, 37), moderately high (7, 24),
and very high (27) baseline levels of p21 expression. Because
conventional biochemical techniques have limitations in sensi-
tivity and specificity arising from variations in reagent fidelity,
specimen preparation, and quantification difficulties in many
organs, there is considerable interest in imaging gene expres-
sion and signaling pathways noninvasively in their normal phys-
iological context within living organisms (10, 17). With that
intent, transgenic reporter mice carrying a p21 LacZ transgene
(37) as well as a p21 firefly luciferase (FLuc) transgene (29)
have been developed and described. However, design strate-
gies limited the output of these reporter strains. For example,
both studies used a truncated p21 promoter to drive reporter
expression and therefore eliminated key signaling inputs reg-
ulating p21 promoter activity. In addition, in one case, reporter
mice contained 2, 3, or 22 copies of the p21 transgene and
therefore did not accurately report endogenous levels of ex-
pression (37).
Therefore, to monitor both p53-dependent and -indepen-
dent regulation of the endogenous p21 promoter in the proper
context of a vertebrate animal, we generated knock-in reporter
mice, in which expression of the FLuc gene is placed under the
control of the endogenous p21 promoter. We demonstrate that
expression of luciferase accurately reports endogenous p21
expression at baseline and following ionizing radiation (IR),
enabling the activity of the endogenous p21 promoter to be
dynamically monitored in real time in vivo, under a variety of
experimental conditions. Known functions of p21 were vali-
dated noninvasively and in a tissue-specific manner. Imaging of
reporter murine embryonic fibroblasts (MEFs) demonstrated
that p53 prevents the ERK/MAPK pathway from activating
p21 expression when quiescent cells are stimulated to reenter
the cell cycle with serum, while imaging of reporter mice re-
vealed novel sites of high-level p21 expression.
MATERIALS AND METHODS
This study was carried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of the National Research
Council (28). The Committee on the Ethics of Animal Experiments at Wash-
ington University approved all animal protocols used in the study.
Construction of the p21-targeting vector. PCR was used to amplify 129/SvJ
genomic DNA encoding p21 (Invitrogen). The 5-targeting arm was generated
using primers 5-GAT CCC CGG TCC TTG TGA A-3 and 5-CCA TGG TGC
CTG TGG CTG AAA C-3. This amplified 4.0 kb of p21 genomic DNA begin-
ning within intron 1 and ending in exon 2 just after the start codon. The primer
design inserted an NcoI site within the ATG start codon in exon 2. The 3-
targeting arm was generated using primers 5-TGT CCG ACC TGT TCC GCA
CAG-3 and 5-GGT AAG ACC AGG GAA TCC CAC-3. This amplified 1.8 kb
of p21 genomic DNA extending from within exon 2 to noncoding sequences
downstream of exon 3. PCR products were inserted into the Topo TA vector
(Invitrogen). A BamHI/NcoI fragment encoding the 5-targeting arm was then
inserted into BglII/NcoI sites of the pGL3-Basic vector (Promega) to generate
pGL3-mp21/5 (8.8 kb). p1339 (GenBank accession number AF335419) was used
to assemble the targeting vector (a gift from the Siteman Cancer Center at
Washington University). p1399 contains a loxP-flanked PGK-Neo cassette (phos-
phoglycerate kinase promoter driving expression of neomycin phosphotransfer-
ase). The 1.8-kb EcoRI/EcoRI 3 arm was cloned into EcoRV-digested p1339 to
generate p1339-mp21/3. The 5.9-kb MluI/BamHI fragment from pGL3-mp21/5
was then cloned into KpnI-digested p1339-mp21/3 to generate the final targeting
vector (mp21-pGL3).
Generation of reporter mice. RW4 embryonic stem (ES) cells (Siteman Cancer
Center at Washington University) were electroporated with NotI-linearized tar-
geting vector and selected with Geneticin (G418; Invitrogen) using established
protocols (Siteman Cancer Center Murine Embryonic Stem Cell Core). A total
of 144 G418-resistant ES cell colonies were analyzed for homologous recombi-
nation. Genomic DNA was digested with EcoRV followed by Southern blotting
using a 5 Southern probe (primers Forward, 5-GCG ATA TCC AGA CAT
TCA GAG-3, and Reverse, 5-GGA ATC CCT AGA AAC ATT GGC-3). ES
cell clone 70 was selected, and homologous recombination was confirmed for the
3 arm by PCR using two primers (5-TCT TGT GTT TCA GCC ACA GGC-3
and 5-CAA TGC AGG GGG TTG CCA CT-3). ES cell clone 70 was deter-
mined to have a normal karyotype and was expanded and electroporated with a
plasmid carrying Turbo-Cre recombinase under the control of the chicken -ac-
tin promoter to remove the PGK-Neo cassette. A total of 51 ES cell clones were
analyzed for excision of the PGK-Neo cassette. Genomic DNA was digested with
EcoRV followed by Southern blotting with the 5 Southern probe and PCR using
the same primers as described above for the 3 arm to identify clones lacking the
Neo cassette. ES cell clone 70-58 was selected and found to have a normal
karyotype. This clone was microinjected into C57BL/6 blastocysts, which were
subsequently implanted into the uteri of pseudopregnant C57BL/6  C3H foster
mothers. Male chimeras selected based on the percentage of agouti color were
mated to C57BL/6 females. Germ line transmission was determined by agouti
coat color. F1 animals were tested for the targeted p21 allele by PCR analysis of
tail DNA. PCR analysis of tail DNA was performed with three primers (a,
5-TCT TGT GTT TCA GCC ACA GGC-3; b, 5-CTG TCA GGC TGG TCT
GCC TCC-3; c, 5 CGA ACG GAC ATT TCG AAG TAC-3). The sizes of the
wild-type (WT) and recombinant alleles were 453 bp and 208 bp, respectively.
The Trp53/ mouse line was obtained from Jackson Labs (catalog number
000058). All mice were crossed to 129X1/SvJ and B6(Cg)-Tyrc-2J/J mice to obtain
a white coat color for imaging.
Generation and culturing of MEFs. MEFs were generated as described pre-
viously (12), cultured in a 5% O2 incubator, and frozen at passage 2. MEFs were
cultured in complete MEF medium consisting of Dulbecco’s modified Eagle’s
medium (DMEM; high glucose with L-glutamine; Gibco,) supplemented with
10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 U/ml streptomycin
(Gibco), 2 mM L-glutamine (Gibco), 100 M nonessential amino acids (Gibco),
and 140 M 2-mercaptoethanol (Bio-Rad). Imaging experiments were per-
formed in black-walled 24-well plates (Midwest Scientific, St. Louis, MO) in
medium lacking phenol red and containing 0.5 mM D-luciferin (Biosynth). All
experiments were conducted with early-passage cells (P2 to P5), and at least
three different lines were used for each genotype. Cells were irradiated in a 60Co
source. Serum starvation experiments were performed with cells plated at sub-
confluency. A total of 0.2  104 to 0.7  104 cells were seeded in 24-well
black-walled tissue culture dishes for BLI and 0.5  105 to 2  105 cells were
seeded in 10-cm tissue culture dishes for Western blotting. One day after plating,
cells were washed twice with low-serum MEF medium (0.1% FBS) and cultured
in low-serum medium for 48 h. Cells were then incubated in low-serum medium
with the indicated concentrations of U0126 (Promega) in dimethyl sulfoxide
(DMSO; Sigma) or DMSO alone for 30 min, followed by incubation in MEF
medium containing 10% FBS and supplemented with the indicated concentra-
tions of U0126 or vehicle (DMSO). Bioluminescence imaging was performed
using an IVIS Lumina or IVIS 50 apparatus (Caliper) with identical instrument,
field-of-view, f-stop, exposure, and binning settings within an experiment (16).
shRNA. For shRNA knockdown, lentiviruses were produced using pLKO.1
plasmids that contained shRNA sequences and were cotransfected with packag-
ing plasmids as described previously (36). shRNA sequences were tested for p53
knockdown (pLKO.1 shTrp53, CCG ACC TAT CCT TAC CAT CAT; RNAi
Consortium) and compared to a scrambled control (pLKO.1 Scr, CCTAA
GGTTA AGTCG CCCTC GCTCT AGCGA GGGCG ACTTA ACCTT AGG;
Addgene) (31). All cells were selected in puromycin (2 g/ml; Invitrogen).
Real-time PCR. RNA was isolated from MEFs by using the RNeasy kit
(Qiagen). RNA was reverse transcribed with random primers (SuperScript II;
Invitrogen). Standard curves were generated using cDNA from p53/ and
p53/ MEFs of each sample within an experiment. The standard curve for each
primer was generated from the logarithmic equation fitting the cycle thresholds
for 400, 200, 100, 25, 12.5, and 1 ng, and all R2 values were greater than 0.99. The
standard curve was run on each plate at least in duplicate. Each sample was
tested in triplicate at 50 ng cDNA, except in the p53/ samples, where p21 and
FLuc levels at 50 ng were outside the linear range of the standard curve, and so
these samples were run in triplicate undiluted from the cDNA reaction mixture.
Real-time PCR was performed with SYBR green master mix (Agilent) and a 100
nM concentration of the specific primer set, in a Bio-Rad CFX96 PCR instru-
ment (95°C for 10 min, then 40 cycles of 95°C for 30 s, 61°C for 1 min, and 74°C
for 1 min). Primers were the following: p21 forward, 5-GAC AAG AGG CCC
AGT ACT TCC T-3; p21 reverse, 5-CAA TCT GCG CTT GGA GTC ATA-3;
FLuc forward, 5-CGT CGC CAG TCA AGT AAC AAC C-3; FLuc reverse,
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5-CAC GGC GAT CTT TCC GCC-3; 18S forward, 5-CAT TCG AAC GTC
TGC CCT ATC-3; 18S reverse, 5-CCT GCT GCC TTC CTT GGA-3.
For whole-tissue RNA extraction, mice were perfused with diethyl pyrocar-
bonate-treated phosphate-buffered saline (PBS) followed by a 3-min perfusion
with RNALater (Ambion). Organs were then dissected and flash-frozen in
RNALater. RNA was isolated from homogenized whole tissues by using TRIzol
(Invitrogen). Quality of whole-tissue RNA was determined by gel electrophoresis
or spectrophotometry, and only intact samples were analyzed. RNA was reverse
transcribed with random primers (SuperScript II; Invitrogen). cDNA was pooled
from whole-tissue lysates to generate a standard curve. All samples were run in
triplicate with 50 ng cDNA. Real-time PCR was performed as described above.
RNA was isolated from laser capture microdissected tissue using the RNeasy
microkit (Qiagen). RNA was reverse transcribed using the High-Capacity cDNA
reverse transcription kit (Applied Biosystems). Real-time PCR was performed
using TaqMan primers and probes for p21 (Mm00432448_m1) and actin
(4352341E; Applied Biosystems). Due to the small volume of RNA isolated from
laser capture microdissection, a standard curve could not be generated, and the
	CT method was used for analysis. Relative expression levels of p21 and FLuc
were calculated by normalizing to actin or 18S levels (see Fig. 2, 4C, and 7B) and
then to mock-irradiated samples within each genotype (see Fig. 4F), to p21
mRNA (see Fig. 7C), or to wild-type control levels (see Fig. 12).
Western blotting. Cells were lysed in mammalian cell lysis buffer (MCLB; 50
mM Tris-HCl [pH 8.0], 2 mM dithiothreitol, 5 mM EDTA, 0.5% NP-40, 100 mM
NaCl, 1 mM microcystin [Sigma Chemical Co.], 1 mM sodium orthovanadate, 2
mM phenylmethylsulfonyl fluoride) supplemented with protease (Sigma Chem-
ical Co.) and phosphatase inhibitor (Calbiochem) cocktails. Clarified lysates
were resolved by SDS-PAGE (10%/15% layered SDS gel) and transferred to
nitrocellulose membranes for Western blotting. Membranes were blocked in
TBST (20 mM Tris-HCl [pH 7.6], 137 mM NaCl, 0.1% Tween 20) containing 5%
nonfat milk and incubated overnight in primary antibody diluted in either
TBST–1% nonfat milk or TBST–5% BSA containing 0.05% sodium azide. Mem-
branes were washed in TBST, incubated with fluorescent- or horseradish perox-
idase (HRP)-conjugated secondary antibody for 1 h in TBST–1% nonfat milk,
and washed again in TBST. Blots were analyzed using the Odyssey imaging
system (LI-COR Biosciences) or incubated with the enhanced chemilumines-
cence system (Pierce) and exposed to film. Quantification was performed in
ImageJ (2). Primary antibodies included anti-p21 at 1:1,000 (F5; Santa Cruz
Biotechnology), anti-FLuc at 1:10,000 (sc6246; Santa Cruz Biotechnology), anti-
actin at 1:10,000 (A4700; Sigma Chemical Co.), anti-p53 at 1:1,000 (1C12; Cell
Signaling), antitubulin at 1:1,000 (YL1/2; AbCam/2), anti-cyclophillin A at
1:1,000 (2175; Cell Signaling), anti-phospho-p44/42 Erk1/2 at 1:1,000
(D13.14.4E; Cell Signaling), and anti-p44/42 Erk1/2 at 1:2,000 (L34F12; Cell
Signaling). Secondary antibodies for the Odyssey system were from LI-COR
Biosciences and included donkey anti-rabbit IRDye-800CW, donkey anti-mouse
IRDye-800CW, and donkey anti-mouse IRDye680CW. Secondary antibodies for
autoradiography were peroxidase conjugated, AffiniPure goat anti-mouse (Jack-
son), HRP–rabbit anti-rat (Zymed), and HRP–goat anti-rabbit (Invitrogen).
Immunohistochemistry. Mouse tissues were fixed in Bouin’s solution (Sigma
Chemical Co.) overnight, progressively dehydrated through gradients of ethanol,
and then paraffin embedded. Tissues were sectioned at a thickness of 5 m.
Trilogy (Cell Marque) was used for deparaffinization, rehydration, and antigen
retrieval. Vaginal sections were blocked using Rodent Block M (Biocare) and
then incubated with anti-FLuc antibody (sc6246; Santa Cruz Biotechnology)
diluted 1:1,000 in PBS containing 3% nonfat milk and 0.1% Triton X-100 at 4°C
overnight. Sections were washed and then incubated with secondary antibody
Alexa-Fluor 594 goat anti-rabbit (Invitrogen) at room temperature for 1 h.
Secondary antibody was diluted 1:1,000 in fluorescent diluent (Biocare) with XR
factor (1:300; Biocare). Images were acquired on an Olympus BX61 microscope
with a Hamamatsu ORCA R2 monochrome camera and the Microsuite Biolog-
ical Suite software. Images were processed equally for signal intensity and color
merge by using ImageJ (2). Penis sections were prepared and incubated with
anti-FLuc antibody as described above, with an additional blocking step of 3%
H2O2 in methanol for 30 min to block endogenous peroxidase activity immedi-
ately following antigen retrieval. Tissue sections were washed in PBS and incu-
bated with secondary anti-rabbit antibody–HRP (no dilution; Dako) at room
temperature for 1 h. Slides were washed in PBS, incubated in freshly made
diaminobenzidine substrate (Invitrogen) for 5 min, rinsed in distilled water
followed by PBS, and counterstained with hematoxylin (Invitrogen). Images were
acquired with an Olympus BX51 microscope with an Olympus DP71 color
camera using the Olympus Controller software.
Bioluminescence imaging of mice and organs. Reporter mice were implanted
with microosmotic pumps (Alzet 1007D; 0.5 l/h for 7 days) containing 100 l of
50-mg/ml D-luciferin (Biosynth) as described previously (15). Pumps were im-
planted at least 16 h before the start of the experiment to allow for equilibration
of D-luciferin and mouse recovery. For irradiation experiments, mice were placed
in a chamber, transported to a 137Cs source irradiator, and exposed to the
indicated dose of IR or remained outside the irradiator chamber (mock group).
Imaging was performed using an IVIS Lumina device (Caliper), and mice were
anesthetized with 1.5% isoflurane through an O2 flow modulator. Mice were
anesthetized for 10 min in a holding tank and allowed to equilibrate in the IVIS
for 15 min, and then the image was acquired (60 s; binning, 4). Photon flux was
measured at baseline by drawing a rectangular region of interest (ROI) from the
forepaws to slightly above the genitals for each mouse. The ROI was duplicated
each time the mouse was imaged. The genitals and bladder were eliminated from
the ROI because of the large variation in signal generated from this region of the
mouse by excretion of D-luciferin. Data were expressed as total photon flux
(photons/s) or normalized as fold increases, expressed as posttreatment/pretreat-
ment and/or posttreatment/vehicle image ratios. For ex vivo experiments, a pre-
dissection image was taken as described above. Mice were then sacrificed and
organs were rapidly removed, weighed, placed in individual wells of a 24-well
black-wall plate, and imaged within 25 min of sacrifice (30-s exposure; binning,
4). Corresponding gray-scale photographs and color luciferase images were su-
perimposed and analyzed with LivingImage 3.2 (Caliper) and Igor (Wavemet-
rics) image analysis software.
Low-light microscopy. Male and female p21/FLuc mice were sacrificed and
organs isolated (small intestine, liver, and penis or vagina). Organs were placed
in ice cold Hanks buffered saline solution (HBSS; pH 7.4; Sigma Chemical Co.).
Livers were sectioned into 200-m sections on a vibratome (immersed in HBSS
maintained at 4°C), and the small intestine and vagina were cut into 200-m
sections using a tissue chopper. Penises were cut longitudinally to create a flat
surface, and then sections were cut using two attached razor blades with a
300-m spacer between them. Organ sections were placed on an organotypic
Millicell culture insert (Millipore) in a 35-mm petri dish containing HEPES-
buffered DMEM supplemented with B27 (Invitrogen), 0.1 mM D-luciferin
(BioThema), and 100 U/ml penicillin, 100 U/ml streptomycin (Gibco). Small
intestines were incubated in crypt culture medium composed of Advanced
DMEM/F-12 (Gibco), 50 ng/ml EGF (Peprotech Inc.), 100 ng/ml Noggin (Pep-
rotech Inc.), 500 ng/ml R-spondin (R&D Systems) containing 10 M D-luciferin
(BioThema) (32). All images were completed within 3 h of organ isolation.
Penises and vaginas were incubated in 1 nM SYTO 11 green fluorescent nucleic
acid stain (Invitrogen). To orient vaginal tissue, the lumen was stained with
SYPRO ruby (Invitrogen), a protein-binding fluorescent dye. All images were
obtained with a Versarray back-thinned illuminated charge-coupled-device
(CCD) camera (Princeton Instruments) or an iXon DU-897E EM CCD camera
(Andor Technology). Cameras were coupled to a TE-2000 Nikon inverted mi-
croscopes equipped with custom light-tight environmental chambers (InVivo
Scientific) that prevented light leaks and kept a constant temperature of 37°C.
Image acquisition was controlled with Winview32 and Micro-Manager (www
.Micro-Manager.org) software packages. Image processing was performed with
ImageJ software (2) and included subtraction of a background image, removal of
random bright spots (using the despeckle filtering algorirthm in ImageJ), and
adjusting the brightness and contrast equally across the entire image. Intensity-
scale ramps were scaled and normalized to the time over which the image was
acquired and are represented as relative light units (RLU)/min. Pseudocolored
images were generated using the RainbowRGB look-up table (LUT) on the
bioluminescence image, which was then merged to the bright-field image.
Isolation and culturing of primary hepatocytes from reporter mice. Primary
hepatocytes were isolated from p21/FLuc mice by hepatic portal collagenase
perfusion as described previously (19, 20). Briefly, the liver was perfused with
collagenase (Sigma Chemical Co.), the liver sheath was disrupted, and cells were
passed through a 70-m filter. Cells were washed twice with DMEM, and dou-
ble-nucleated hepatocytes were pelleted at 65  g and plated in collagen-1-
coated 6-well plates (BD Biosciences) in DMEM (Invitrogen) supplemented
with 10% fetal bovine serum (non-heat inactivated), 100 U/ml penicillin, 100
U/ml streptomycin (Gibco). The next day, the medium was changed to hepato-
cyte imaging medium (same as above except with phenol red-free DMEM
[Gibco] and 0.5 mM D-luciferin [Biosynth]). Cells were allowed to equilibrate for
1 h, and bioluminescence was measured using the IVIS Lumina (Caliper) as
described above for MEFs.
Laser capture microdissection. Tissues were dissected from p21/ or
p21FLuc/FLuc mice, immediately frozen in optimal cutting temperature (OCT)
compound (TissueTek), and stored at 80°C. Sections of 15 to 20 m were cut
on a cryostat and were placed on PEN membrane slides (Leica). Unstained slides
were stored in a desiccator at 80°C. Tissues were fixed in 70% ethanol (20 s)
and rehydrated in RNase-free water (10 times). Nuclei were stained with methyl
green (10 times; Vector), rinsed in RNase-free water, counterstained with
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EosinY (2 times), and dehydrated in ethanol (70%, 95%, 95%, 100%, and 100%)
for 1 min each. Slides were rinsed in xylene and dried in a desiccator for at least
5 min immediately prior to laser capture microdissection. Tissue sections were
dissected using the Leica LMD7000 laser capture microdissection system.
Statistics. All statistics were performed using Graphpad Prism software or
SPSS software. Specific statistical tests performed are noted with the data. All
error bars are the standard errors of the means (SEM).
RESULTS
Generation of p21 reporter mice. Knock-in mice expressing
firefly (Photinus pyralis) luciferase from the endogenous p21
promoter were generated to monitor the spatial and temporal
regulation of p21 (Cdkn1a) gene expression in vitro and in vivo
by BLI (Fig. 1A). Homologous recombination in ES cell clones
was confirmed by Southern blotting (Fig. 1B and C) and PCR
analysis (Fig. 1D and E), while genotyping of offspring was
performed by PCR analysis of mouse tail DNA (Fig. 1F).
Whole-body bioluminescence was detected in both heterozy-
gous (/FLuc) and homozygous (FLuc/FLuc) knock-in mice
but not wild-type (/) mice (Fig. 1G).
Characterization of p21 promoter activity in reporter-de-
rived MEFs. MEFs were generated as a way to determine if
FLuc expression accurately reflected endogenous p21 expres-
sion. Bioluminescence of MEFs derived from wild-type
(p21/) mice was within background levels as expected, while
bioluminescence of MEFs derived from heterozygous knock-in
animals (p21/FLuc) was 307-fold over the background. Biolu-
minescence of MEFs derived from homozygous knock-in ani-
mals (p21FLuc/FLuc) was 2.2-fold higher than MEFs derived
from heterozygous (p21/FLuc) littermates (Fig. 2A and B).
p21/ MEFs contained 
1.5-fold more p21 mRNA than did
p21/FLuc MEFs (Fig. 2C). Correspondingly, FLuc mRNA was
absent in p21/ MEFs and present at 
1.8-fold-higher levels
in p21FLuc/FLuc MEFs than in p21/FLuc MEFs (Fig. 2C). West-
ern blotting revealed an approximate 50% decrease in p21
FIG. 1. Generation of p21-FLuc reporter mice. (A) Structure of the targeting vector, wild-type p21 genomic allele (), and recombinant allele
before (r) and after (FLuc) Cre-mediated excision. The coding region of the mouse p21 gene was disrupted by insertion of codon-optimized firefly
luciferase cDNA (FLuc) containing simian virus 40 poly(A) sequences and a neomycin phosphotransferase cDNA cassette (Neo) driven by the
phosphoglycerine kinase promoter as a selectable marker. Upon homologous recombination, the FLuc cDNA utilizes the ATG start codon of
endogenous p21 in exon 2. The orientation of Neo cassette coding sequences was opposite to that of FLuc. Exons are represented by black boxes;
EcoRV sites are denoted by RV; loxP sites as shown as blue triangles; the 5 Southern probe is indicated by a gray box; 3 PCR primers are
indicated by the red arrows, and genotyping primers are shown as black arrows and in lowercase letters. Sizes of expected Southern blotting and
PCR products are indicated. (B) Genomic DNA from ES cell clone 70 was digested with EcoRV. Southern blotting was performed using the 5 probe
represented by the gray box in panel A. The wild-type allele () gave rise to a 5.9-kb digestion product, and the recombined allele (r) gave rise to a 9.6-kb
digestion product. (C) Genomic DNA from ES cell clone 70-58 was digested with EcoRV. Southern blotting was performed using the 5 probe
represented by the gray box in panel A. The wild-type allele () gave rise to a 5.9-kb digestion product, the recombined allele (r) with the Neo cassette
still present gave rise to a 9.6-kb digestion product, and the recombined allele with the Neo cassette removed gave rise to a 7.7-kb product. Size markers
are indicated on the left, and product sizes are on the right. (D) Genomic DNA isolated from either a BAC clone containing p21, tail DNA from a
wild-type mouse (WT), or two ES cell clones was amplified using PCR primers (represented by red arrows in panel A). The wild-type allele () gave
rise to a 1.9-kb product, and the recombined allele (-) gave rise to a 5.6-kb product. (E) Genomic DNA isolated from ES cell clone 70 (/r) and 70-58
(/FLuc) was amplified using the PCR primers represented by red arrows in panel A. The wild-type allele () gave rise to a 1.9-kb product, the
recombined allele (-) with the Neo cassette still present gave rise to a 5.6-kb product, and the recombined allele with the Neo cassette removed gave rise
to a 3.8-kb product. Size markers are indicated on the left, and product sizes are shown on the right. (F) PCR analysis of tail DNA from wild-type (/),
heterozygous (HT; /FLuc), or homozygous (KI; FLuc/FLuc) knock-in mice amplified with primers indicated by the black arrows (a, b, and c) in panel
A. The WT () allele produced a 453-bp product with primers a and b, and the recombinant (FLuc) allele produced a 208-bp product from primers a
and c. (G) WT, HT, or KI mice were shaved and implanted with D-luciferin microosmotic pumps and imaged using the IVIS Lumina system (Caliper).
Representative images of mice at baseline are shown. Photon flux is indicated in the pseudocolored heat map.
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protein in p21/FLuc MEFs relative to WT MEFs, and FLuc
protein levels were 
2-fold higher in p21FLuc/FLuc MEFs rel-
ative to p21/FLuc MEFs (Fig. 2D). Overall bioluminescence,
mRNA, and protein levels correlated with the p21 WT allele
copy number (Table 1). These results indicate that reporter
activity accurately reflects basal p21 promoter expression.
Characterization of p21 promoter activity in reporter MEFs
lacking p53. To monitor p21 promoter activity in both the
presence and absence of p53, reporter mice along with their
wild-type littermates were crossed to Trp53/ mice, followed
by intercrossing to obtain p21/FLuc reporter mice with litter-
mates wild type or null for Trp53. Compared to p21/FLuc
littermates (p53 wild type), no difference in baseline promoter
activity was observed with whole-body BLI (Fig. 3A and B) or
in isolated organs of p53-null p21/FLuc reporter mice, with the
exception of white adipose tissue (WAT), where enhanced
bioluminescence was measured in p53-null WAT relative to
p53 WT WAT (P  0.016) (Fig. 3C). Early-passage heterozy-
gous reporter MEFs were also generated and subjected to BLI.
In contrast to live mice, basal bioluminescence measured in
p21/FLuc MEFs lacking p53 was 
20% of that measured in
reporter MEFs with wild-type p53 (Fig. 4A, panels 1 and 3, and
B). mRNAs encoding p21 and FLuc were significantly reduced
in p53-null heterozyous reporter MEFs relative to their p53
wild-type counterparts (9% and 10% of WT, respectively) (Fig.
4C). Similarly, both p21 and FLuc proteins were also reduced
in the absence of p53 (Fig. 4D, lanes 1 and 3).
Next, MEFs were imaged to obtain baseline values and then
either mock irradiated or exposed to 2.5 Gy of irradiation.
Cells were then reimaged at various time points after irradia-
tion. Representative bioluminescence images are shown in Fig.
4A, and data obtained at 4 and 12 h postirradiation are dis-
played graphically (Fig. 4E). Results confirmed previously pub-
lished findings (11) demonstrating that IR activates the p21
promoter in a p53-dependent manner, and they further vali-
dated that reporter MEFs accurately reflect endogenous p21
promoter activity in response to IR. Protein (Fig. 4D) as well
as mRNAs encoding p21 and FLuc (Fig. 4F) accumulated
FIG. 2. p21 promoter activity in reporter MEFs. (A and B) MEFs
of the indicated genotypes were plated at equal densities in quadru-
plicate, and bioluminescence activity was determined. Representative
wells are depicted by a pseudocolored heat map (A), and photon flux
was plotted (B). (C) Relative levels of p21 and FLuc mRNAs were
determined by quantitative reverse transcription-PCR in MEF lines,
and values were normalized to 18S rRNA. (D) Western blotting was
performed to determine relative levels of p21 and FLuc in each MEF
line, and actin was used as a loading control.
TABLE 1. Pearson coefficients for baseline bioluminescence,
mRNA, and protein levels within p21/, p21/FLuc,
and p21FLuc/FLuc MEFs
Assay r value P value
Bioluminescence 0.70 0.005
p21 mRNA 0.88 0.002
FLuc mRNA 0.74 0.090
p21 protein 0.97 0.001
FLuc protein 0.99 0.001
FIG. 3. p21 expression in wild-type and Tpr53-null mice. p21/FLuc
Trp53/ (n  14) and p21/FLuc Trp53/ (n  9) mice were im-
planted with D-luciferin microosmotic pumps, and whole-body images
were obtained. (A and B) Compiled results were plotted (A), and
representative mice are also shown (B). (C) Mice were sacrificed, and
individual organs were isolated, weighed, and then imaged ex vivo.
Bioluminescence of each organ is represented as the photon flux/
sample weight (photons/s/g). Individual mice (squares and circles) and
the group average (bars) are shown. The Mann-Whitney U Test P
values are indicated at the top of each column.
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concordantly in irradiated reporter MEFs in a p53-dependent
manner.
Regulation of p21 expression during cell cycle reentry from
quiescence. Next, the contribution made by p53 to the ability of
MEFs to reenter the cell cycle from quiescence was examined.
p21/FLuc reporter MEFs that were either wild type or null for
p53 were cultured in 0.1% serum for 48 h in order to induce
growth arrest (Fig. 5A). As seen in Fig. 5B, there was a signif-
icant decrease in bioluminescence over the 48-h period, and
the observed loss of p21 expression was independent of p53
status. Interestingly, p21 expression was induced when p53-null
but not p53 wild-type MEFs were cultured in 10% FBS to
stimulate cell cycle reentry (Fig. 5B). The ERK/MAPK path-
way has been shown to activate p21 expression in response to
serum stimulation (6, 25). Therefore, we tested whether inhi-
bition of MEK (with the kinase inhibitor U0126) blocked in-
duction of p21 expression by serum restimulation. Cells that
had been cultured in 0.1% FBS for 47.5 h were treated with
either vehicle (DMSO) or a range of U0126 concentrations for
30 min. After the 30-min preincubation period, cells were
cultured in medium containing 10% FBS together with either
DMSO or U0126, and BLI was performed at the indicated
time points. Photon flux was normalized to baseline values
obtained from cells cultured in 0.1% FBS for 48 h (t 0 in Fig.
5A). Note that an approximate 6-fold induction of biolumines-
cence was measured in p53-null cells within 5 h of culturing in
10% FBS (Fig. 5C), and a dose-dependent inhibition of p21
expression by U0126 was observed under these conditions (Fig.
5C and D). This suggests that in the absence of p53, serum
stimulation acts through the ERK/MAPK pathway to activate
p21 expression. As is shown in Fig. 5B, serum stimulation was
ineffective at inducing p21 expression in p53 wild-type MEFs
(Fig. 5E), and in p53 wild-type MEFs, inhibition of p21 expres-
sion was only observed at the very highest doses of U0126 (30
and 100 M), where off-target effects of the drug are expected
(Fig. 5E and F). Western blotting revealed that p21 protein
levels were also elevated when p53-null but not wild-type
MEFs were stimulated with serum, and the ability of serum to
increase p21 was blocked by U0126 (Fig. 5G). Note that 10%
FBS stimulated ERK phosphorylation, and this was blocked
with 10 M U0126 in both p53 wild-type and null MEFs (Fig.
5H). Taken together these findings suggest that p53 blocks
quiescent MEFs from activating p21 expression in response to
serum stimulation. Given that ERK phosphorylation is in-
duced normally under these conditions, the block in signaling
must be at a point downstream of ERK/MAPK activation
(Fig. 6E).
If p53 prevents the ERK/MAPK pathway from activating
p21 expression in serum-stimulated quiescent cells, then
knockdown of p53 should result in activation of the p21 pro-
moter and increased levels of p21 protein in p53 wild-type
MEFs under these conditions. As seen in Fig. 6A, efficient
knockdown of p53 was achieved in p53 wild-type MEFs upon
lentiviral infection. Importantly, when p53 was knocked down,
p21 levels rose following serum stimulation (Fig. 6B, lanes 5
and 6, and C), and this response was inhibited by U0126 (Fig.
6B, lanes 6 and 8, and C). Bioluminescence followed similar
trends, in that knockdown of p53 now sensitized p21 expression
to U0126 (Fig. 6D). As expected, p21 levels did not rise when
quiescent p53 wild-type MEFs expressing scrambled shRNAs
were cultured in 10% FBS (Fig. 6B, lanes 1 and 2, and C), and
U0126 treatment did not decrease overall levels of p21 in these
cells (Fig. 6B, lanes 2 and 4, and C).
Analysis of p21 promoter activity in individual organs of
reporter mice. Individual organs were freshly isolated from
reporter mice to determine the localization and intensity of
basal p21 promoter activity in vivo (Fig. 7 and 8). To account
for size differences between various organs within a single
mouse as well as the same organ in different mice, organ
photon flux was normalized to organ weight. As seen in Fig. 7,
values measured in individual organs ranged from 1  106 to
1  109 photons/s/g. Bioluminescence was detected in every
organ that was examined; even the low signals measured in
blood, heart, brain, and spleen were above background levels.
These results suggested that the p21 promoter was ubiquitously
active in unperturbed mice. Within the quantitative limits in-
FIG. 4. IR activates the p21 promoter in a p53-dependent manner
in vitro. All experiments were performed with p21/FLuc MEFs with the
indicated p53 status. MEFs were plated at equal densities, and biolu-
minescence was measured at baseline (t  0) and at 4 and 12 h after
mock irradiation or exposure to 2.5 Gy of IR. (A) Representative
images of MEFs obtained 12 h after IR. (B) Absolute photon flux
values at baseline. *, P  0.015, two-tailed t test. (C to E) To plot the
response to IR, data were normalized to the baseline value for each
replicate and then to the mock-irradiated sample (P  0.001 by 2-way
analysis of variance [ANOVA], comparing Trp53/ MEFs to
Trp53/ MEFs. ***, P  0.001 by Bonferroni posttest of 2-way
ANOVA results. Additionally, MEFs were mock irradiated or exposed
to 2.5-Gy IR, and 12 h later mRNA was isolated. Levels of p21 and
FLuc mRNA 12 h post-IR relative to a standard curve and 18S rRNA
(C) as well as normalized to mock-irradiated samples within each
genotype (F) are shown. MEFs were mock irradiated or exposed to
5-Gy IR and harvested 4 h later, and Western blotting was performed
for the indicated proteins (D). Different exposures using the Odyssey
imaging system are shown. A higher intensity (I) is equivalent to a
longer exposure time. For experiments involving BLI and relative
mRNA determinations, 3 separate MEF lines were used per genotype,
and each line was plated in at least triplicate per treatment.
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troduced by different optical densities of the various tissues
(21), bioluminescence was greatest in the penis, bladder, va-
gina, intestines, femur (containing bone marrow), skin, and
WAT. To confirm that FLuc mRNA levels accurately repre-
sented endogenous p21 mRNA levels, RNA was isolated from
livers, spleens, kidneys, and small intestines of p21/FLuc mice,
and p21 and FLuc mRNA levels were quantitated. As seen in
Fig. 7B and C, p21 and FLuc mRNA levels were concordant in
FIG. 5. Regulation of p21 expression during cell cycle reentry from quiescence. (A) Overall experimental strategy yielding the results shown in panels
B to H. Cells were plated at subconfluency and the following day incubated in medium containing 0.1% FBS for 47.5 h. Cells were then cultured in
medium (0.1% FBS) in the absence or presence of DMSO for 30 min, followed by culturing in medium containing 10% FBS in the presence or absence
of DMSO. (B) BLI was performed at the indicated time points. Photon flux measured at each time point was normalized to photon flux measured prior
to serum starvation. A Bonferroni posttest of a 2-way ANOVA showed significance between the Trp53/and Trp53/ response. Differences were not
observed between DMSO and untreated cells within a given genotype., P 0.001. Cells were plated at subconfluency and the following day incubated
in medium containing 0.1% FBS for 47.5 h. (C to H) Cells were then cultured in medium (0.1% FBS) containing DMSO or the indicated concentrations
of U0126 for 30 min, followed by culturing in medium containing 10% FBS together with either DMSO or U0126. BLI (C to F) and Western blotting
(G and H) were performed at the indicated times. Photon flux was normalized to baseline values obtained from cells cultured in 0.1% FBS for 48 h (C
and D) followed by normalization to DMSO-treated samples (D and F). The inset in panel D is a dose-response curve generated from the data shown
in panel D for the 4-h time points. The inset in panel E is the same data shown in panel E but expanded on a different scale. Asterisks in panels C to
F represent significance as tested by Bonferroni posttest comparing U0126 doses to DMSO from a 2-way ANOVA. , P  0.001; , P  0.05; ns,
nonsignificant. Cells were harvested at the 4-h time point for Western blotting (G and H). Film exposure times in panel G were 15 s (p21 short exposure),
5 min (p21 long exposure), or 30 min (tubulin), and in panel H exposure times were 5 s (pERK), 30 s (ERK), and 30 s (tubulin). Relative p21 expression
shown in panel G was first normalized to tubulin, followed by normalization to the indicated control sample.
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all tissues with the exception of liver, where Fluc mRNA levels
were slightly higher than p21 mRNA levels.
Analysis of p21 promoter activity in irradiated reporter
mice. Mice were subjected to whole-body irradiation to deter-
mine if IR activates the endogenous p21 promoter in a p53-
dependent manner in vivo. Baseline images were obtained, and
then mice were either mock irradiated or exposed to 2.5-Gy
IR. Mice were then reimaged at various times posttreatment.
Representative images are shown at 0 and 8 h posttreatment
(Fig. 9A), and data are presented graphically in Fig. 9B.
Whole-body bioluminescence of p53 wild-type reporter mice
increased following IR treatment and peaked by 8 h. Biolumi-
nescence then steadily declined until 24 h post-IR and re-
mained stable but above baseline out to 36 h. Enhanced bio-
luminescence was not observed in reporter mice lacking p53
relative to mock-irradiated mice, confirming that p53 regulates
the p21 promoter in response to IR in vivo. Note the small, but
highly reproducible, p53-independent transient increase in bio-
luminescence for several hours after the procedure (perhaps
related to handling the mice during transport to and from the
FIG. 6. p53 inhibits activation of the p21 promoter during cell cycle reentry from quiescence. (A) MEFs infected with recombinant lentiviruses
encoding either control or p53-specific shRNA were lysed and analyzed by Western blotting. The displayed data are representative of 3
independent experiments performed in three different MEF lines. (B to D) MEFs expressing control or p53-specific shRNAs were plated and
treated as illustrated in Fig. 5A. Representative Western blots are shown (B), and compiled data from three separate experiments are shown
graphically (C). Exposure times in panel B were 2 min (tubulin, p21 [Trp53/ samples]), and 10 s (p21 [Trp53/ samples]). BLI was performed
at the indicated time points. Photon flux was normalized to baseline values obtained from cells cultured in 0.1% FBS for 48 h followed by
normalization to DMSO-treated samples (D). Asterisks in panel D represent significance as tested by Bonferroni posttest comparing U0126 doses
to DMSO with a 2-way ANOVA. , P  0.001; ns, nonsignificant. (E) Model based on data shown in Fig. 5 and here. t.f., transcription factor.
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irradiator), an apparent stress response we have observed in all
groups during a variety of procedures.
Next, individual organs were isolated 8 h after treatment to
determine which organs contributed to the increase in whole-
body bioluminescence following IR (Fig. 9C and D). Biolumi-
nescence was observed to increase in nearly all organs tested,
but most significantly in small intestines and pancreas. Other
organs that showed a significant increase were brain, large
intestine, salivary gland, spleen, lung, and heart (Mann-Whit-
ney U test) (Fig. 9C). No significant change was detected in
response to IR in the peritoneal lining, liver, kidney, stomach,
skin, cecum, femur containing bone marrow, or skeletal muscle
(Fig. 9D). IR has previously been reported to increase p21
mRNA and protein levels in small and large intestines (7, 27,
38), brain (7, 24, 27), salivary gland (18), spleen (7, 24, 27),
lung (7, 24, 27), and heart (7, 24), but the observed increase in
the pancreas was a novel finding of our study.
p21 promoter activity in specific regions of individual or-
gans. To localize the origin of luciferase activity within specific
regions of individual organs, we employed low-light micros-
copy (Fig. 10). Imaging was performed using microscopes with
custom-built, light-tight environmental chambers to avoid ex-
ternal light leaks and to control for temperature. Organs were
isolated, immediately sectioned, and then placed in appropri-
ate buffers to maintain viability. In some cases, SYTO 11 green
fluorescent stain was used to visualize nucleic acid (nuclei) and
SYPRO ruby was used as a protein stain. Tissue autofluores-
cence (Autofluor) was used to complement bright-field imag-
ing. Bright-field (Fig. 10, column 1) and bioluminescent (Fig.
10, column 2) images were acquired for all tissues; the latter
are represented as pseudocolored heat maps over the bright-
field images in column 3. p21 promoter activity was visualized
throughout the villi of the small intestines and just inferior to
the villi in the superior regions of crypts (Fig. 10A). This
indicated that p21 expression was turned on as cells exited their
proliferative phase and began to terminally differentiate into
the various epithelial cell types of the small intestine. p21
promoter activity was widely dispersed throughout the liver,
and fractionation studies confirmed luciferase activity in
freshly isolated hepatocytes (Fig. 10B). p21 promoter activity
was also observed in the epithelial cell layer under the kera-
tinized penile spines (Fig. 10C and D). The autofluorescence
of the spine validated that luciferase activity originated from
the base of the spine and not from within the spine itself (Fig.
10D, columns 4 and 5). Finally, p21 promoter activity was
localized to the epithelial cell layer of the vagina (Fig. 10E).
The vaginal lumen was identified by bathing it in SYPRO ruby
protein stain prior to dissection (column 5). SYTO 11 nucleic
acid stain was used to identify the adventitia and muscularis
layers of the vagina (column 4). As seen in column 6, biolu-
minescence was detected between these two markers, specifi-
cally, in the epithelial cell layer. Immunofluorescent staining
confirmed that FLuc protein was specifically localized to the
epithelial cell layer of the vagina (Fig. 11A), and immunohis-
tochemistry confirmed that FLuc is localized in the epithelium
at the base of penile spines (Fig. 11B). Finally, laser capture
microdissection followed by real-time PCR confirmed that en-
dogenous p21 mRNA was present in the epithelial layers of the
vagina and penis (Fig. 12). Taken together, we conclude that
the endogenous p21 promoter is widely active under basal
conditions in organs throughout the body as well as in cell-
type-specific compartments and niches of these organs not
previously appreciated.
DISCUSSION
We generated and characterized knock-in p21 luciferase re-
porter mice, and this enabled noninvasive, real-time monitor-
ing of endogenous p21 promoter activity, both spatially and
temporally, in the context of living mice and in cells derived
from these mice. To validate these reporter mice, we asked
whether p53 was required for basal and damage-induced ex-
pression of the p21 promoter in mice and in MEFs. In addition,
we analyzed p53-dependent and -independent regulation of
p21 expression as cells reentered the cell cycle from quies-
cence.
Loss of p53 had profound effects on basal expression of the
p21 promoter in cultured MEFs (Fig. 4). In contrast to live
mice, there was a 5-fold reduction in baseline bioluminescence
measured in early-passage MEFs obtained from p53-null mice
compared with p53 wild-type mice. A decrease in p21 promoter
activity was also validated at the level of both mRNA (Fig. 4C)
and protein (Fig. 4E). These findings indicated that the p21
FIG. 7. Reporter expression in individual mouse organs. p21/FLuc
mice were implanted with D-luciferin microosmotic pumps for 1 to 3
days. Mice were sacrificed and organs were imaged ex vivo. To account
for variation in organ size from mouse to mouse, organ weights were
determined prior to BLI. (A) Bioluminescence of each organ is rep-
resented as photon flux/sample weight (photons/s/g). The graph was
plotted using a logarithmic scale, and the dotted line represents the
background signal detected in organs of WT mice. Relative levels of
p21 and FLuc mRNA were determined by quantitative reverse tran-
scription-PCR in the indicated organs of p21/FLuc mice (n  3), and
values were normalized to 18S rRNA (B), followed by normalization to
p21 mRNA (C). Asterisks note where the RNA isolated was not of a
high enough quality for analysis.
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promoter was activated in MEFs in a p53-dependent manner
as a result of culturing cells ex vivo, consistent with a process
that has been termed “culture shock” (33). As expected, the
ability of IR to induce p21 promoter activity in MEFs required
a functional p53 pathway (Fig. 4). An increase of p21 promoter
activity was also observed in reporter mice following IR expo-
sure, which was also p53 dependent (Fig. 9). Organ analysis ex
vivo demonstrated that post-IR signals increased in all organs
tested but most significantly in the small intestine, pancreas,
and brain.
p21 expression has been shown to be activated in response to
serum stimulation through the ERK/MAPK pathway. This
leads to assembly of cyclin D/CDK4 complexes in order to
promote cell cycle progression (6, 9, 22, 25, 27). We observed
activation of p21 expression and increases in p21 protein when
quiescent MEFs were stimulated by serum, but only in Trp53-
null cells (Fig. 5 and 6). The addition of serum to early-passage
quiescent Trp53 wild-type MEFs induced MEK activation as
evidenced by increases in ERK phosphorylation, but the p21
promoter was not activated (Fig. 6E). Thus, p53 appears to
FIG. 8. Bioluminescence in individual organs of reporter and control mice. p21/FLuc and p21/ mice were implanted with D-luciferin
microosmotic pumps. Organs were dissected, and bioluminescence was determined within 25 min of sacrifice. (A) Organs from the same female
reporter mouse (p21/FLuc) and the penis from a male p21/FLuc reporter mouse. (B) Organs isolated from a male wild-type control mouse
(p21/). Organ bioluminescence is represented as a pseudocolored heat map superimposed on the organ in the upper panel, and the same
photograph of the organ is provided in the lower panel. Scale bars for the heat maps are provided in each panel.
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block quiescent wild-type MEFs from activating p21 expression
upon serum stimulation at a point downstream of ERK/MAPK
activation. Future studies will examine p21 promoter occu-
pancy by ERK/MAPK-regulated transcription factors both in
the presence and absence of p53.
Previous studies of p21 expression levels in various organs of
mice (at the level of endogenous protein or endogenous
mRNA or in transgenic reporter mice) reported that baseline
expression of p21 is independent of p53 status (7, 27, 29, 37,
38). Of note, these observations were generally confirmed in
our knock-in strain (Fig. 7 and 8), but the sensitivity of biolu-
minescence imaging enabled us to detect effects of loss of p53
function on expression of p21 in mouse white adipose tissue
(Fig. 3). In addition, several other organs trended toward sig-
nificance. Due to the robust bioluminescence generated in our
reporter mice, we were able to use microosmotic pumps to
deliver a constant supply of D-luciferin to all tissues in selected
experiments, which enabled protocols for imaging mice se-
quentially and repetitively over short or long intervals, there-
fore enhancing the capacity for dynamic analysis (15).
In contrast to the knock-in mice reported here, previously
published studies of transgenic reporter mice carrying a p21
LacZ transgene (37) or a p21 firefly luciferase (FLuc) trans-
gene (29) did not accurately report p21 promoter activity in
vivo. For example, baseline expression of the p21 promoter was
reported to be highest in the kidney and forepaws, whereas the
FIG. 9. IR activates the p21 promoter in a p53-dependent manner in vivo. p21/FLuc Trp53/ and p21/FLuc Trp53/ mice were imaged (time
zero) and then either mock irradiated or exposed to 2.5-Gy IR. Whole-body bioluminescence was determined at the indicated times posttreatment.
(A) Representative images of mice; (B) bioluminescence relative to the value at time zero, displayed graphically. , P  0.05; , P  0.01 by
Bonferroni posttests of a 2-way ANOVA. (C and D) p21/FLuc Trp53/ mice were either mock irradiated or exposed to 2.5-Gy IR, and organs
were harvested 8 h later and immediately imaged. To account for variations in organ size from mouse to mouse, organ weight was determined prior
to BLI. The normalized photon flux of each organ is represented as the photon flux/sample weight (photons/s/g). Individual mice (squares and
circles) and the group average (bar) are shown. The Mann-Whitney U test P value is included in each column.
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small intestine was one of the lowest-expressing organs in a p21
FLuc transgenic strain (29). In contrast, in our knock-in re-
porter mice, the small intestine (Fig. 7 and 8) was one of the
highest-expressing organs, as expected (7, 27), while kidney
(Fig. 7 and 8) and forepaw (Fig. 8) were among the lowest. In
the transgenic models, a truncated p21 promoter of 2.5 kb (29)
or 4.5 kb (37) drives reporter expression. In one case, the
reporter strain contained 2, 3, or 22 copies of the transgene
(37), whereas in the other case, the number of copies was not
documented (29). Baseline expression of the p21 promoter in
the p21 LacZ mice was only detected in the strain with 21
copies of the transgene (37), and bioluminescence in the p21
FLuc transgenic strain did not exceed 106 photons/s (29).
This is in contrast to the high baseline bioluminescence of
109 photons/s measured in our reporter mice under similar
conditions. The observed differences between the transgenic
strains and our knock-in strain are likely due, in part, to the
deletion of many important regulatory regions in the trun-
cated promoters used to create the transgenic reporter lines,
as well as gene loci and related positional effects on reporter
activity (4).
Given recent advances in cooled CCD cameras and our
interest in tracking p21 expression at high resolution, low-light
bioluminescence microscopy allowed us to observe p21 pro-
FIG. 10. Bioluminescence microscopy revealed p21 promoter activity within organs. Tissue sections of the small intestine (A), liver (B), penis
(C and D), and vagina (E) isolated from p21/FLuc mice were incubated with D-luciferin-containing medium, and BLI was performed. Column 1
is the bright-field image, column 2 is the bioluminescence image, and column 3 is the pseudocolor overlay of bioluminescence on the bright field.
In some cases, tissue autofluorescence (autofluor) was photographed, and tissues were stained with SYPRO ruby protein stain and/or with SYTO
11 green fluorescent nucleic acid stain. Pseudocolor overlays of fluorescence and bioluminescence images are depicted. Bars, 200 m (10
magnifications) or 50 m (40 magnifications).
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moter activity within specific regions of mouse tissues. We
observed p21 promoter activity in the differentiated epithelia
of various organs (penis, vagina, and small intestine) as well as
in liver hepatocytes, a relatively quiescent cell population (Fig.
10). The observation of p21 expression in differentiated epi-
thelia of the external genitalia was novel. The ability to use
microscopy to visualize p21 expression provides an additional
advantage, as bioluminescence microscopy does not require
potentially cytotoxic excitation light and typically has extremely
low background signals (13). The real-time nature of FLuc-
based tracking of reporters in eukaryotic cells also allows serial
measurements from the same region over time (16). Hence,
FIG. 11. Localization of FLuc protein in mouse vagina and penis. Tissue sections of vaginas (A) and penises (B) isolated from p21FLuc/FLuc and
p21/ mice were stained with antibodies specific for FLuc (red in panel A, brown in panel B) and counterstained with 4,6-diamidino-2-
phenylindole (DAPI) for nuclei (blue in panel A) and hematoxylin (B). Representative images in panel A are shown at 10 and 40magnification
and in panel B at 100 magnification. Arrows are included in panel B to mark the epithelial cells. Bars, 100 m.
FIG. 12. Localization of p21 mRNA in epithelial cells of vagina and
penis. Epithelial cells from vaginas and penises isolated from p21/
(n  3 for each sex) and p21FLuc/FLuc (n  2 for each sex) mice were
isolated using laser capture microdissection. mRNA was isolated, and
relative levels of p21 mRNA were determined by normalizing to actin
mRNA and p21/ samples. Individual mice (circles and squares) and
the group average (bars) are shown. Each sample was tested in tripli-
cate, and the SEM is also shown.
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bioluminescence microscopy is well-suited to kinetic studies of
p21 expression in specific regions of organs not previously
amenable to analysis.
In summary, we generated knock-in luciferase reporter mice
in which the p21 gene locus was targeted, and these mice will
be particularly useful for elucidating more fully the many
known upstream regulators of p21 promoter activity in vivo
and, due to the ease of bioluminescence imaging, also will be
useful for characterizing novel p53-independent regulators of
the p21 promoter in living mice.
ACKNOWLEDGMENTS
We thank Jiling Song, Sofia Origanti, and Courtney Robinson for
technical support during the early stages of this project. We thank
Mike White for performing blastocyst injections, Chris Ryan and Em-
ily Powell for editorial assistance, and Reece Goiffon for assistance
with statistics. Shin-ichiro Imai and Cindy Brace are thanked for help
in isolating and culturing primary hepatocytes. Raleigh Kladney is
thanked for help with mouse perfusions. Jason Weber and Jason T.
Forys are thanked for advice on experiments related to serum starving
of MEFs. We thank the Alvin J. Siteman Cancer Center at Washington
University School of Medicine and Barnes-Jewish Hospital for the use
of the Embryonic Stem Cell Core and electroporation services. The
RNAi Consortium of the Broad Institute and the Children’s Discovery
Institute are thanked for providing shRNAs.
This study was supported in part by grant P50 CA94056 to the
Molecular Imaging Center at Washington University, by P30
NS057105 to Washington University, by NIH grant MH63140 to
E.D.H., and by a DOD Prostate Cancer Research Program Training
Award Grant (PC101951) to K.L.T. H.P.-W. is a Research Professor of
the American Cancer Society. The Siteman Cancer Center is sup-
ported in part by an NCI Cancer Center Support Grant (P30
CA91842).
REFERENCES
1. Abbas, T., and A. Dutta. 2009. p21 in cancer: intricate networks and multiple
activities. Nat. Rev. Cancer 9:400–414.
2. Abramoff, M. D., P. J. Magelhaes, and S. J. Ram. 2004. Image processing
with ImageJ. Biophotonics Int. 11:36–42.
3. Abukhdeir, A. M., and B. H. Park. 2008. p21 and p27: roles in carcinogenesis
and drug resistance. Expert Rev. Mol. Med. 10:e19.
4. al-Shawi, R., J. Kinnaird, J. Burke, and J. O. Bishop. 1990. Expression of a
foreign gene in a line of transgenic mice is modulated by a chromosomal
position effect. Mol. Cell. Biol. 10:1192–1198.
5. Besson, A., S. F. Dowdy, and J. M. Roberts. 2008. CDK inhibitors: cell cycle
regulators and beyond. Dev. Cell 14:159–169.
6. Bottazzi, M. E., X. Zhu, R. M. Bohmer, and R. K. Assoian. 1999. Regulation
of p21Cip1 expression by growth factors and the extracellular matrix reveals
a role for transient ERK activity in G1 phase. J. Cell Biol. 146:1255–1264.
7. Bouvard, V., et al. 2000. Tissue and cell-specific expression of the p53-target
genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradia-
tion in mice. Oncogene 19:649–660.
8. Cazzalini, O., et al. 2010. p21CDKN1A participates in base excision repair by
regulating the activity of poly(ADP-ribose) polymerase-1. DNA Repair
(Amst.) 9:627–635.
9. Cheng, M., et al. 1999. The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essen-
tial activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J.
18:1571–1583.
10. Dothager, R. S., et al. 2009. Advances in bioluminescence imaging of live
animal models. Curr. Opin. Biotechnol. 20:45–53.
11. el-Deiry, W. S. 1998. Regulation of p53 downstream genes. Semin. Cancer
Biol. 8:345–357.
12. Ferguson, A. M., L. S. White, P. J. Donovan, and H. Piwnica-Worms. 2005.
Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B
and Cdc25C protein phosphatases. Mol. Cell. Biol. 25:2853–2860.
13. Flentie, K. N., et al. 2008. Stably integrated luxCDABE for assessment of
Salmonella invasion kinetics. Mol. Imaging 7:222–233.
14. Gartel, A. L., and A. L. Tyner. 1999. Transcriptional regulation of the
p21WAF1/CIP1 gene. Exp. Cell. Res. 246:280–289.
15. Gross, S., U. Abraham, J. L. Prior, E. D. Herzog, and D. Piwnica-Worms.
2007. Continuous delivery of D-luciferin by implanted micro-osmotic pumps
enables true real-time bioluminescence imaging of luciferase activity in vivo.
Mol. Imaging 6:121–130.
16. Gross, S., and D. Piwnica-Worms. 2005. Real-time imaging of ligand-in-
duced IKK activation in intact cells and in living mice. Nat. Methods 2:607–
614.
17. Gross, S., and D. Piwnica-Worms. 2005. Spying on cancer: molecular imag-
ing in vivo with genetically encoded reporters. Cancer Cell 7:5–15.
18. Humphries, M. J., et al. 2006. Suppression of apoptosis in the protein kinase
C	 null mouse in vivo. J. Biol. Chem. 281:9728–9737.
19. Klaunig, J. E., et al. 1981. Mouse liver cell culture. I. Hepatocyte isolation.
In Vitro 17:913–925.
20. Klaunig, J. E., P. J. Goldblatt, D. E. Hinton, M. M. Lipsky, and B. F. Trump.
1981. Mouse liver cell culture. II. Primary culture. In Vitro 17:926–934.
21. Klerk, C. P., et al. 2007. Validity of bioluminescence measurements for
noninvasive in vivo imaging of tumor load in small animals. Biotechniques
43(1 Suppl.):7–13.
22. LaBaer, J., et al. 1997. New functional activities for the p21 family of CDK
inhibitors. Genes Dev. 11:847–862.
23. Lee, S., and D. M. Helfman. 2004. Cytoplasmic p21Cip1 is involved in Ras-
induced inhibition of the ROCK/LIMK/cofilin pathway. J. Biol. Chem. 279:
1885–1891.
24. Lee, W. J., et al. 2006. Organ-specific gene expressions in C57BL/6 mice after
exposure to low-dose radiation. Radiat. Res. 165:562–569.
25. Liu, Y., J. L. Martindale, M. Gorospe, and N. J. Holbrook. 1996. Regulation
of p21WAF1/CIP1 expression through mitogen-activated protein kinase signal-
ing pathway. Cancer Res. 56:31–35.
26. Luo, Y., J. Hurwitz, and J. Massague. 1995. Cell-cycle inhibition by inde-
pendent CDK and PCNA binding domains in p21Cip1. Nature 375:159–161.
27. Macleod, K. F., et al. 1995. p53-dependent and independent expression of
p21 during cell growth, differentiation, and DNA damage. Genes Dev.
9:935–944.
28. National Research Council. 1996. Guide for the care and use of laboratory
animals. National Academy Press, Washington, DC.
29. Ohtani, N., et al. 2007. Visualizing the dynamics of p21Waf1/Cip1 cyclin-
dependent kinase inhibitor expression in living animals. Proc. Natl. Acad.
Sci. U. S. A. 104:15034–15039.
30. Parker, S. B., et al. 1995. p53-independent expression of p21Cip1 in muscle
and other terminally differentiating cells. Science 267:1024–1027.
31. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005.
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
Science 307:1098–1101.
32. Sato, T., et al. 2009. Single Lgr5 stem cells build crypt-villus structures in
vitro without a mesenchymal niche. Nature 459:262–265.
33. Sherr, C. J., and R. A. DePinho. 2000. Cellular senescence: mitotic clock or
culture shock? Cell 102:407–410.
34. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative
regulators of G1-phase progression. Genes Dev. 13:1501–1512.
35. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-
dependent kinases. Genes Dev. 9:1149–1163.
36. Stewart, S. A., et al. 2003. Lentivirus-delivered stable gene silencing by RNAi
in primary cells. RNA 9:493–501.
37. Vasey, D. B., C. R. Wolf, T. MacArtney, K. Brown, and C. B. Whitelaw. 2008.
p21-LacZ reporter mice reflect p53-dependent toxic insult. Toxicol. Appl.
Pharmacol. 227:440–450.
38. Wilson, J. W., D. M. Pritchard, J. A. Hickman, and C. S. Potten. 1998.
Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intesti-
nal epithelium: apoptosis and cell cycle arrest. Am. J. Pathol. 153:899–909.
3772 TINKUM ET AL. MOL. CELL. BIOL.
 o
n
 January 11, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
